Frontotemporal dementia (FTD) is the most common form of dementia before 60 years of age. Rare pathogenic mutations in CHMP2B, which encodes a component of the endosomal sorting complex required for transport (ESCRT-III), are associated with FTD linked to chromosome 3 (FTD3). Animal models of FTD3 have not yet been reported, and what signaling pathways are misregulated by mutant CHMP2B in vivo is unknown. Here we report the establishment of a Drosophila model of FTD3 and show the genetic interactions between mutant CHMP2B and other components of ESCRT. Through an unbiased genome-wide screen, we identified 29 modifier loci and found that serpin5 (Spn5), a largely uncharacterized serine protease inhibitor, suppresses the melanization phenotype induced by mutant CHMP2B in the fly eye. We also found that Spn5 is a negative regulator of the Toll pathway and functions extracellularly, likely by blocking the proteolytic activation of Spaetzle, the Toll receptor ligand. Moreover, Spn5 inhibited activation of the Toll pathway by mutant CHMP2B. Our findings identify Spn5 as a regulator of the Toll pathway and CHMP2B toxicity and show that the Toll pathway is a major signaling pathway misregulated by mutant CHMP2B in vivo. This fly model will be useful to further dissect genetic pathways that are potentially relevant to the pathogenesis and treatment of FTD.Drosophila ͉ endosomal sorting complex required for transport (ESCRT) ͉ neurodegeneration ͉ modifier screen F rontotemporal dementia (FTD), a major clinical syndrome of frontotemporal lobar degeneration (FTLD), is a progressive neurodegenerative condition associated with focal atrophy of the frontal and/or temporal lobes (1, 2). Although FTD is the most common form of senile dementia in people under 60 years of age, the molecular pathogenesis remains poorly understood (3). In some FTD brains, tau neurofibrillary tangles are present in diseased neurons, and some tau mutations are indeed pathogenic (4, 5). Several new genes have been implicated in FTD with tau-negative pathology, including those encoding valosin-containing protein (VCP) (6), CHMP2B (7), progranulin (8, 9), and TDP-43 (10, 11). The molecular pathways affected by these mutations and how they contribute to disease progression remain unclear.Although dominantly inherited CHMP2B mutations associated with FTD linked to chromosome 3 (FTD3) are rare (7,12,13), studies of CHMP2B neurotoxicity in cell culture models have been informative. CHMP2B is the ortholog of the yeast protein Vps2, a component of the endosomal sorting complex required for transport (ESCRT-III), which is involved in the biogenesis of multivesicular bodies and other biological processes (14). In undifferentiated PC12 cells, ectopic overexpression of CHMP2B Intron5 , a mutant form of CHMP2B missing 35 aa at the C terminus, led to the accumulation of vesicular structures (7). In cultured rodent cortical neurons and other cell types, CHMP2B Intron5 caused dendritic retraction, autophagosome accumulation, and neuronal cell loss (15,16). At the mol...